Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)

Clinical trial NCT01411696 · COMPLETED

Trial details

NCT number: NCT01411696
Sponsor: Allergan
Status: COMPLETED
Study type: OBSERVATIONAL

Retinal Vein Occlusion Macular Edema

Start date: 2011-07-01
Primary completion: 2012-03-01
Enrollment: 289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.